本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

8.60
-0.3100-3.48%
成交量:51.70萬
成交額:447.01萬
市值:4.20億
市盈率:-2.68
高:9.03
開:8.89
低:8.49
收:8.91
52周最高:14.53
52周最低:2.22
股本:4,888.58萬
流通股本:1,898.44萬
量比:1.41
換手率:2.72%
股息:- -
股息率:- -
每股收益(TTM):-3.2084
每股收益(LYR):-3.4309
淨資產收益率:-36.58%
總資產收益率:-22.34%
市淨率:1.21
市盈率(LYR):-2.51

資料載入中...

2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/01/29

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/22

重要事件披露

Form 8-K - Current report
2024/09/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/29

重要事件披露

Form 8-K - Current report
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/17

SEC問詢函

Form CORRESP - Correspondence